Please refer attachment

3rd August, 2026 BSE Limited National Stock Exchange of India Limited P.J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra-Kurla Complex, Mumbai- 400 001 Bandra (East), Mumbai – 400 051 BSE scrip code: 543635 NSE symbol: PPLPHARMA Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Resumption of operations at Company’s facilities located at Ahmedabad, Gujarat Dear Sir / Madam, This is further to our communication dated 24th July, 2026, regarding temporary suspension of operations at the Company's manufacturing facilities located at Plot Nos. 18 and 19 – PHARMEZ - Pharmaceutical Special Economic Zone, Village Matoda, Sarkhej Bawla, NH 8A, Taluka Sanand, Ahmedabad - 382 213, Gujarat, India, due to exceptionally heavy rainfall and flooding across parts of Gujarat. We wish to inform you that operations have resumed across substantially all areas of the aforesaid facilities, with only limited restoration and recommissioning activities ongoing in certain sections. The Company has completed a preliminary assessment of the impact on its assets and operations and has initiated the insurance claim process. Based on the assessment undertaken to date, the Company does not expect any material impact on its operations or financial performance. This is for your information and records Thank you. Yours truly, For Piramal Pharma Limited Maneesh Sharma Company Secretary & Compliance Officer Piramal Pharma Limited CIN: L24297MH2020PLC338592 Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com www.piramalpharma.com